Shine-On BioMedical Co.,Ltd. Statistics
Total Valuation
Shine-On BioMedical Co.,Ltd. has a market cap or net worth of TWD 3.25 billion. The enterprise value is 2.16 billion.
Market Cap | 3.25B |
Enterprise Value | 2.16B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Shine-On BioMedical Co.,Ltd. has 49.80 million shares outstanding. The number of shares has increased by 2.03% in one year.
Shares Outstanding | 49.80M |
Shares Change (YoY) | +2.03% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 24.42M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 341.45 |
PB Ratio | 2.98 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -30.53 |
EV / Sales | 227.09 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -35.74 |
Financial Position
The company has a current ratio of 56.04, with a Debt / Equity ratio of 0.29.
Current Ratio | 56.04 |
Quick Ratio | 55.54 |
Debt / Equity | 0.29 |
Debt / EBITDA | n/a |
Debt / FCF | -0.05 |
Interest Coverage | -9,038.40 |
Financial Efficiency
Return on equity (ROE) is -6.29% and return on invested capital (ROIC) is -5.01%.
Return on Equity (ROE) | -6.29% |
Return on Assets (ROA) | -4.96% |
Return on Capital (ROIC) | -5.01% |
Revenue Per Employee | 501,263 |
Profits Per Employee | -3.73M |
Employee Count | 19 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.03% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +2.03% |
50-Day Moving Average | 65.19 |
200-Day Moving Average | 64.83 |
Relative Strength Index (RSI) | 52.61 |
Average Volume (20 Days) | 6,352 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shine-On BioMedical Co.,Ltd. had revenue of TWD 9.52 million and -70.83 million in losses. Loss per share was -1.42.
Revenue | 9.52M |
Gross Profit | 6.67M |
Operating Income | -90.38M |
Pretax Income | -69.73M |
Net Income | -70.83M |
EBITDA | -89.65M |
EBIT | -90.38M |
Loss Per Share | -1.42 |
Balance Sheet
The company has 1.09 billion in cash and 3.21 million in debt, giving a net cash position of 1.09 billion or 21.87 per share.
Cash & Cash Equivalents | 1.09B |
Total Debt | 3.21M |
Net Cash | 1.09B |
Net Cash Per Share | 21.87 |
Equity (Book Value) | 1.09B |
Book Value Per Share | 21.89 |
Working Capital | 1.08B |
Cash Flow
In the last 12 months, operating cash flow was -60.48 million and capital expenditures -34,000, giving a free cash flow of -60.52 million.
Operating Cash Flow | -60.48M |
Capital Expenditures | -34,000 |
Free Cash Flow | -60.52M |
FCF Per Share | -1.22 |
Margins
Gross Margin | 70.00% |
Operating Margin | -949.01% |
Pretax Margin | -732.18% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -635.41% |
Dividends & Yields
Shine-On BioMedical Co.,Ltd. does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.03% |
Shareholder Yield | -2.03% |
Earnings Yield | -2.18% |
FCF Yield | -1.86% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |